0001209191-22-034811.txt : 20220607
0001209191-22-034811.hdr.sgml : 20220607
20220607160135
ACCESSION NUMBER: 0001209191-22-034811
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220603
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brandenberger Ralph
CENTRAL INDEX KEY: 0001853197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 221001216
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 102
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-582-4923
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-03
0
0001787400
Nkarta, Inc.
NKTX
0001853197
Brandenberger Ralph
C/O NKARTA, INC.
6000 SHORELINE COURT, SUITE 102
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Sr. VP, Technical Operations
Common Stock
2022-06-03
4
M
0
340
0.41
A
5640
D
Common Stock
2022-06-03
4
M
0
405
4.77
A
6045
D
Common Stock
2022-06-03
4
M
0
1358
3.89
A
7403
D
Common Stock
2022-06-03
4
M
0
2037
3.89
A
9440
D
Common Stock
2022-06-03
4
S
0
4140
15.00
D
5300
D
Stock Option (right to buy)
0.41
2022-06-03
4
M
0
340
0.00
D
2028-07-18
Common Stock
340
7367
D
Stock Option (right to buy)
4.77
2022-06-03
4
M
0
405
0.00
D
2029-05-10
Common Stock
405
8785
D
Stock Option (right to buy)
3.89
2022-06-03
4
M
0
1358
0.00
D
2029-09-05
Common Stock
1358
29426
D
Stock Option (right to buy)
3.89
2022-06-03
4
M
0
2037
0.00
D
2029-09-05
Common Stock
2037
44139
D
The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
This stock option is fully vested.
The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.
The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.
The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.
/s/ Alicia Hager, as Attorney-in-Fact
2022-06-07